Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • narges
    Member
    • Aug 2012
    • 29

    Spike in dataset to compare DESeq vs cuffdiff

    Hi all,

    I wanted to ask if you have any idea to be fair as much as possible when comparing two RNA-seq analysis methods like DESeq and cuffdiff. I know one ideal option is using spikein datasets, or alternatively a simulated dataset but then I have no clue about if there are any publicly available spikein dataset for RNA-seq.
    Any help or idea would be appreciated.
  • Wolfgang Huber
    Senior Member
    • Aug 2009
    • 109

    #2
    Dear Narges

    simulation is great to check how well your software does (or approximates) what your theory says, but it does not help with the question whether your theory (or: model) agrees with reality.

    As for real data, two criteria that seem to make sense are specificity (how many or few false positives do you find) and sensitivity (how many true positives do you find). As for specificity, this is in fact quite easy with real data, just do the same comparison that you would like to do, but in a "mock" fashion with all samples actually being biological replicates. For sensitivity, you need a "ground truth" of truly differentially expressed genes. These may be hard to come by - but you can use prior biological knowledge, independent experiments, etc. Also, this ground truth does not need to be strictly true for the purpose of method ranking, it is sufficient if it is enriched for truth, and the false genes in there are random (the concept of 'pseudo-ROC' by Richard Bourgon).

    Best wishes
    Wolfgang
    Wolfgang Huber
    EMBL

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM
    • GATTACAT
      Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
      by GATTACAT
      Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
      07-01-2026, 11:43 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-07-2026, 11:05 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Working...